多囊卵巢综合征：以药物治疗方法为重点的治疗选择综述
Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches.
作者信息
Ndefo Uche Anadu, Eaton Angie, Green Monica Robinson
出版信息
P T. 2013 Jun;38(6):336-55.
Abstract
Oral contraceptives, antidiabetes drugs, and statins are some of the therapies used to address the symptoms of this complex hormonal condition. Weight loss and surgery may also be beneficial as non-drug options.
摘要
口服避孕药、抗糖尿病药物和他汀类药物是用于治疗这种复杂激素状况症状的一些疗法。减肥和手术作为非药物选择可能也有益处。
相似文献
1
2
New Therapeutic Approaches in Obesity and Metabolic Syndrome Associated with Polycystic Ovary Syndrome.肥胖及与多囊卵巢综合征相关的代谢综合征的新治疗方法
Cureus. 2017 Nov 13;9(11):e1844. doi: 10.7759/cureus.1844.
3
The obstetrician-gynecologist's role in the practical management of polycystic ovary syndrome.妇产科医生在多囊卵巢综合征实际管理中的作用。
Am J Obstet Gynecol. 1998 Dec;179(6 Pt 2):S109-S113. doi: 10.1016/s0002-9378(98)70241-8.
4
Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome.二甲双胍或口服避孕药或二者联合用于多囊卵巢综合征的疗效与安全性
Ther Clin Risk Manag. 2015 Sep 1;11:1345-53. doi: 10.2147/TCRM.S89737. eCollection 2015.
5
Comparative efficacy of statins, metformin, spironolactone and combined oral contraceptives in reducing testosterone levels in women with polycystic ovary syndrome: a network meta-analysis of randomized clinical trials.比较他汀类药物、二甲双胍、螺内酯和复方口服避孕药降低多囊卵巢综合征女性睾酮水平的疗效：一项随机临床试验的网络荟萃分析。
BMC Womens Health. 2020 Apr 5;20(1):68. doi: 10.1186/s12905-020-00919-5.
6
Chromium supplementation does not improve weight loss or metabolic and hormonal variables in patients with polycystic ovary syndrome: A systematic review.铬补充剂不能改善多囊卵巢综合征患者的体重减轻或代谢和激素变量：系统评价。
Nutr Res. 2018 Aug;56:1-10. doi: 10.1016/j.nutres.2018.04.003. Epub 2018 Apr 13.
7
Pharmacologic therapy of polycystic ovary syndrome.多囊卵巢综合征的药物治疗
Clin Obstet Gynecol. 2007 Mar;50(1):244-54. doi: 10.1097/GRF.0b013e31802f35a0.
8
Noncontraceptive use of oral combined hormonal contraceptives in polycystic ovary syndrome-risks versus benefits.多囊卵巢综合征患者口服复方激素避孕药的非避孕用途——风险与获益。
Fertil Steril. 2016 Dec;106(7):1572-1579. doi: 10.1016/j.fertnstert.2016.10.027. Epub 2016 Nov 3.
9
Treatment options of polycystic ovary syndrome in adolescence.青少年多囊卵巢综合征的治疗选择
Pediatr Endocrinol Rev. 2006 Jan;3 Suppl 1:208-13.
10
A 27-year-old woman with a diagnosis of polycystic ovary syndrome.一名27岁被诊断为多囊卵巢综合征的女性。
JAMA. 2007 Feb 7;297(5):509-19. doi: 10.1001/jama.297.5.509.
引用本文的文献
1
Integrating Computational Analysis of In Vivo Investigation of Modulatory Effect of Plant Extract on Letrozole-Induced Polycystic Ovary Syndrome in Female Rats.整合植物提取物对雌性大鼠来曲唑诱导的多囊卵巢综合征调节作用的体内研究的计算分析
Biology (Basel). 2025 Jul 21;14(7):903. doi: 10.3390/biology14070903.
2
AI-powered diagnosis of ovarian conditions: insights from a newly introduced ultrasound dataset.人工智能助力卵巢疾病诊断：来自新引入超声数据集的见解
Front Physiol. 2025 Jul 8;16:1520898. doi: 10.3389/fphys.2025.1520898. eCollection 2025.
3
The Effects of a Novel Fortified Dairy Product on Weight Loss, Metabolic Profiles, and Endocrine Hormones in Women With Polycystic Ovary Syndrome: A Double-Blind Randomized Controlled Trial.一种新型强化乳制品对多囊卵巢综合征女性体重减轻、代谢谱和内分泌激素的影响：一项双盲随机对照试验
Food Sci Nutr. 2025 Jun 27;13(7):e70506. doi: 10.1002/fsn3.70506. eCollection 2025 Jul.
4
Exploration of Herbal Medicinal Plants and Formulations Available for the Treatment of PCOS: A review.用于治疗多囊卵巢综合征的草药药用植物及制剂探索：综述
JBRA Assist Reprod. 2025 May 15;29(2):367-77. doi: 10.5935/1518-0557.20250006.
5
Evaluating the Impact of rs4025935, rs71748309, rs699947, and rs4646994 Genetic Determinants on Polycystic Ovary Syndrome Predisposition-A Case-Control Study.评估rs4025935、rs71748309、rs699947和rs4646994基因决定因素对多囊卵巢综合征易感性的影响——一项病例对照研究
Life (Basel). 2025 Mar 29;15(4):558. doi: 10.3390/life15040558.
6
Curcumin and its formulations for the treatment of polycystic ovary syndrome: current insights and future prospects.姜黄素及其制剂在多囊卵巢综合征治疗中的应用：当前见解与未来展望
J Ovarian Res. 2025 Apr 15;18(1):78. doi: 10.1186/s13048-025-01660-z.
7
Environmental exposure to selected non-persistent endocrine disrupting chemicals and polycystic ovary syndrome: a systematic review.环境暴露于特定非持久性内分泌干扰化学物质与多囊卵巢综合征：一项系统综述
Int J Occup Med Environ Health. 2025 Apr 23;38(2):98-121. doi: 10.13075/ijomeh.1896.02551. Epub 2025 Apr 7.
8
Effects of a Novel Fortified Dairy Product on the Psychological Status and Sleep Quality of Patients with Polycystic Ovary Syndrome: A Double-Blind Randomized Controlled Trial.一种新型强化乳制品对多囊卵巢综合征患者心理状态和睡眠质量的影响：一项双盲随机对照试验
Prev Nutr Food Sci. 2025 Feb 28;30(1):37-46. doi: 10.3746/pnf.2025.30.1.37.
9
The impact of GABA and GABAergic pathway in polycystic ovary syndrome: a systematic review.γ-氨基丁酸（GABA）及GABA能通路在多囊卵巢综合征中的作用：一项系统综述
Obstet Gynecol Sci. 2025 Mar;68(2):93-108. doi: 10.5468/ogs.24255. Epub 2025 Feb 11.
10
Examining symptom and quality of life in polycystic ovarian syndrome: a web-based cross-sectional study.多囊卵巢综合征的症状与生活质量调查：一项基于网络的横断面研究。
Future Sci OA. 2024 Dec;10(1):2430878. doi: 10.1080/20565623.2024.2430878. Epub 2024 Nov 19.
本文引用的文献
1
Androgen receptor gene polymorphism and polycystic ovary syndrome.雄激素受体基因多态性与多囊卵巢综合征。
Int J Gynaecol Obstet. 2013 Feb;120(2):115-8. doi: 10.1016/j.ijgo.2012.08.016. Epub 2012 Nov 24.
2
Polycystic ovarian syndrome: role of imaging in diagnosis.多囊卵巢综合征：影像学在诊断中的作用。
Radiographics. 2012 Oct;32(6):1643-57. doi: 10.1148/rg.326125503.
3
Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome.腹腔镜下使用透热法或激光打孔以诱导无排卵性多囊卵巢综合征患者排卵。
Cochrane Database Syst Rev. 2012 Jun 13(6):CD001122. doi: 10.1002/14651858.CD001122.pub4.
4
Statin is a reasonable treatment option for patients with Polycystic Ovary Syndrome: a meta-analysis of randomized controlled trials.他汀类药物是多囊卵巢综合征患者的合理治疗选择：一项随机对照试验的荟萃分析。
Exp Clin Endocrinol Diabetes. 2012 Jun;120(6):367-75. doi: 10.1055/s-0032-1304619. Epub 2012 May 25.
5
Polycystic ovary syndrome: a common but often unrecognized condition.多囊卵巢综合征：一种常见但常被忽视的疾病。
J Midwifery Womens Health. 2012 May-Jun;57(3):221-30. doi: 10.1111/j.1542-2011.2012.00161.x.
6
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.用于患有多囊卵巢综合征、月经过少和生育力低下的女性的胰岛素增敏药物（二甲双胍、罗格列酮、吡格列酮、D-手性肌醇）
Cochrane Database Syst Rev. 2012 May 16(5):CD003053. doi: 10.1002/14651858.CD003053.pub5.
7
A systematic review and meta-analysis of randomized controlled trials comparing pioglitazone versus metformin in the treatment of polycystic ovary syndrome.一项比较吡格列酮与二甲双胍治疗多囊卵巢综合征的随机对照试验的系统评价和荟萃分析。
Curr Med Res Opin. 2012 May;28(5):723-30. doi: 10.1185/03007995.2012.681636. Epub 2012 Apr 19.
8
Treating polycystic ovary syndrome and infertility.治疗多囊卵巢综合征和不孕。
MCN Am J Matern Child Nurs. 2012 Mar-Apr;37(2):116-21. doi: 10.1097/NMC.0b013e31824239ce.
9
Clomifene citrate or low-dose FSH for the first-line treatment of infertile women with anovulation associated with polycystic ovary syndrome: a prospective randomized multinational study.枸橼酸氯米酚或小剂量促卵泡激素治疗多囊卵巢综合征相关排卵障碍性不孕的一线治疗：一项前瞻性随机多中心研究。
Hum Reprod. 2012 Feb;27(2):468-73. doi: 10.1093/humrep/der401. Epub 2011 Nov 28.
10
Polycystic ovary syndrome: current infertility management.
Clin Obstet Gynecol. 2011 Dec;54(4):675-84. doi: 10.1097/GRF.0b013e3182353c98.
Zotero 插件